Cranswick (CWK) AI Stock Analysis

• Market Cap: £2.83B
• Dividend Yield: 2.06%
• Average Volume (3M): 108.89K
• Price to Earnings (P/E): 8.4
• Beta (1Y): 0.63
• Revenue Growth: 6.96%
• EPS Growth: 28.47%
• Country: UK
• Employees: 15,000
• Sector: Consumer Defensive
• Sector Strength: 42
• Industry: Packaged Foods
• EPS (TTM): 1.44
• Shares Outstanding: 54,281,776
• 10 Day Avg. Volume: 105,717
• 30 Day Avg. Volume: 108,895
• PEG Ratio: 20.20
• Price to Book (P/B): 2.41
• Price to Sales (P/S): 0.85
• P/FCF Ratio: 17.18
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: £5,823.33
• Price Target Upside: 10.08% Upside
• Rating Consensus: Moderate Buy
• Number of Analyst Covering: 3
• EPS Forecast (FY): 2.94
• Revenue Forecast (FY): £2.98B

• Rating: 78 Outperform
• Price Target: 5,803.00p ▲(9.70% Upside)
• Action: Reiterated Date: 12/07/25
• Date: Action: Reiterated 12/07/25

Cranswick's strong financial performance and positive corporate events are the primary drivers of its solid stock score. Technical indicators support a bullish outlook, while valuation remains fair. The absence of earnings call data limits further insights.

Positive Factors

Revenue Growth

Consistent revenue growth indicates strong market demand and effective sales strategies, supporting long-term business expansion and stability.

Cash Generation

Strong cash generation enhances financial flexibility, enabling reinvestment in growth opportunities and providing a buffer against economic downturns.

Profitability

Sustained profitability reflects effective cost management and operational efficiency, ensuring long-term financial health and shareholder value.

Negative Factors

Leverage

Moderate leverage requires careful management to avoid financial strain, which could impact future investment and growth capabilities.

Revenue Growth Volatility

Volatility in revenue growth could signal market challenges or operational issues, potentially affecting long-term growth projections.

Capital Expenditure Fluctuations

Fluctuating capital expenditures can impact free cash flow stability, affecting the company's ability to fund new projects and maintain growth momentum.

Cranswick Business Overview & Revenue Model

Company Description

Cranswick plc manufactures and supplies food products to grocery retailers, food service sector, and other food producers in the United Kingdom, Continental Europe, and internationally. The company offers fresh pork, gourmet bacon and gammon, fresh and coated chicken, ready to eat chicken, charcuterie, houmous and dips, and olives and antipasti, gourmet sausages, cooked meats, gourmet pastries, and ingredients, as well as cheeses and pasta. It also offers snacks and sharing boxes under the Bodega brand; olives, olive oil, and pulses under the Cypressa brand; Mediterranean foods under the Ramona's Kitchen brand name; and pet food and supplies under the Vitalin and Alpha Feeds, as well as operates export business. The company was incorporated in 1972 and is based in Hessle, the United Kingdom.

How the Company Makes Money

Cranswick generates revenue primarily through the sales of its various food products, focusing on fresh and processed meat items. Key revenue streams include direct sales to major supermarket chains, wholesalers, and foodservice operators. The company's strong relationships with large retailers like Tesco and Sainsbury's help secure significant contracts that provide a stable income. Additionally, Cranswick benefits from its vertically integrated supply chain, which allows for greater control over production costs and quality. The company also invests in product innovation and diversification, introducing new products to meet changing consumer preferences, which further enhances its revenue potential. Partnerships with local farmers and sustainable sourcing practices contribute to its reputation and market presence, ultimately driving sales growth.

Cranswick Financial Statement Overview

Summary

Cranswick exhibits strong financial performance with robust revenue growth, healthy profit margins, and solid cash flow generation. The balance sheet is stable, though moderately leveraged, necessitating careful debt management.

Income Statement

Cranswick demonstrates strong growth in revenue, with a consistent upward trend over the years. The company has managed to maintain a healthy gross profit margin and an improving net profit margin, indicating effective cost management and profitability. EBIT and EBITDA margins are solid, reflecting efficient operations. However, the slight volatility in revenue growth rate needs monitoring.

Balance Sheet

The balance sheet shows a stable financial position with increasing stockholders' equity, indicating retained earnings and strong equity backing. The debt-to-equity ratio remains manageable, reflecting prudent financial leverage. Return on equity is satisfactory, indicating effective utilization of equity. However, the equity ratio suggests a moderately leveraged position, which necessitates careful debt management to maintain stability.

Cash Flow

Cranswick's cash flow statements highlight robust operating cash flow, consistently exceeding net income, which reflects strong cash generation capabilities. Free cash flow growth is positive, though some fluctuations in capital expenditures are noted. The operating cash flow to net income ratio is healthy, indicating efficient conversion of earnings to cash. Continued focus on optimizing capital expenditures would enhance free cash flow stability.

Breakdown	TTM	Mar 2024	Mar 2022	Mar 2021	Mar 2020	Mar 2019
Income Statement
Total Revenue	2.86B	2.72B	2.32B	2.01B	1.90B	1.67B
Gross Profit	444.30M	408.80M	295.70M	276.80M	265.70M	217.60M
EBITDA	308.60M	280.70M	220.00M	199.00M	185.50M	155.20M
Net Income	148.00M	134.30M	111.40M	103.50M	92.50M	82.70M
Balance Sheet
Total Assets	1.72B	1.53B	1.26B	1.14B	1.04B	995.50M
Cash, Cash Equivalents and Short-Term Investments	10.30M	5.90M	20.40M	200.00K	39.90M	23.00M
Total Debt	413.90M	178.30M	121.70M	106.20M	131.40M	168.40M
Total Liabilities	693.00M	543.30M	421.50M	373.60M	355.00M	380.20M
Stockholders Equity	1.02B	987.90M	842.90M	768.90M	686.10M	614.50M
Cash Flow
Free Cash Flow	27.70M	78.70M	64.10M	64.70M	109.00M	14.60M
Operating Cash Flow	206.70M	216.30M	149.20M	158.40M	180.90M	115.80M
Investing Cash Flow	-228.90M	-160.40M	-83.80M	-130.90M	-81.80M	-164.30M
Financing Cash Flow	23.80M	-77.00M	-45.30M	-66.30M	-81.60M	49.50M

Cranswick Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 5290.00
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Positive
• MACD: Positive
• RSI: Neutral
• STOCH: Positive

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For GB:CWK, the sentiment is Positive. The current price of 5290 is below the 20-day moving average (MA) of 5349.50, above the 50-day MA of 5180.80, and above the 200-day MA of 5109.54, indicating a neutral trend. The MACD of 32.61 indicates Positive momentum. The RSI at 49.24 is Neutral, neither overbought nor oversold. The STOCH value of 17.33 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for GB:CWK.

Cranswick Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
CWK	78 Outperform	£2.83B	8.36	15.07%	2.06%	6.96%	28.47%
PFD	76 Outperform	£1.66B	8.95	9.47%	1.62%	0.50%	20.52%
HFG	71 Outperform	£454.43M	11.83	12.72%	7.01%	8.58%	-15.81%
GNC	70 Outperform	£2.04B	17.26	12.23%	0.79%	7.74%	30.09%
ABF	69 Neutral	£13.30B	15.47	9.22%	2.98%	-3.06%	-26.93%
Sector *	62 Neutral	$20.33B	14.63	-3.31%	3.23%	1.93%	-12.26%

Cranswick Corporate Events

Cranswick Director Adds Shares Under Employee Incentive Plan

Cranswick has disclosed that director Christopher Aldersley acquired a small number of ordinary shares under the company’s 2024 Buy As You Earn Share Incentive Plan. The purchase, made on 23 February 2026 via the London Stock Exchange as part of a regular monthly programme, underscores ongoing participation by senior management in Cranswick’s employee share ownership scheme.

The transaction involved the acquisition of two partnership shares at a price of 5,390 pence each, reflecting a routine incentive-related deal rather than a strategic change in ownership. While modest in scale, such purchases can signal continued alignment between the board and shareholders, and support Cranswick’s broader approach to incentivising key personnel through equity participation.

The most recent analyst rating on (GB:CWK) stock is a Buy with a £62.00 price target. To see the full list of analyst forecasts on Cranswick stock, see the GB:CWK Stock Forecast page.

Cranswick Confirms Total Voting Rights and Share Capital

Cranswick plc has confirmed that, as of 30 January 2026, it has 54,281,240 ordinary shares of 10p in issue, with each share carrying one voting right and no shares held in treasury. This disclosure sets the official total voting rights figure that shareholders must use as the denominator when assessing whether they are required to notify the company and regulators of holdings or changes in holdings under the UK’s Disclosure and Transparency Rules, providing clarity for investors and supporting compliance with market reporting requirements.

The most recent analyst rating on (GB:CWK) stock is a Buy with a £62.00 price target. To see the full list of analyst forecasts on Cranswick stock, see the GB:CWK Stock Forecast page.

Cranswick Lifts Profit Expectations After Record Christmas and Broad‑Based Q3 Growth

Cranswick reported strong third‑quarter trading for the 13 weeks to 27 December 2025, with revenue growth across all product categories and record Christmas sales in fresh pork, convenience and gourmet festive ranges, particularly in premium added‑value products. Recent acquisitions, including Blakemans, JSR Genetics and the Fridaythorpe feed mill, are performing ahead of expectations, while poultry revenue was significantly higher year‑on‑year due to improved pricing linked to enhanced welfare practices and new premium retail business; pet products also grew strongly through expanded ranges with Pets at Home. The Group is maintaining a substantial capital investment programme aimed at boosting capacity, capability and efficiencies across key production sites, though full‑year capex is now expected at a lower £160–170m due to project timing, and net debt has risen as anticipated amid this investment and seasonal working‑capital needs. With £360m of committed unsecured facilities, Cranswick says its balance sheet remains robust and that resilient demand for premium pork and poultry, together with its customer relationships, asset base and financial strength, position the business well for continued growth in the current year and beyond.

The most recent analyst rating on (GB:CWK) stock is a Hold with a £5500.00 price target. To see the full list of analyst forecasts on Cranswick stock, see the GB:CWK Stock Forecast page.

Cranswick Director Adds Shares Under Employee Incentive Plan

Cranswick plc has disclosed that director Christopher Aldersley acquired three ordinary shares in the company on 21 January 2026 under its 2024 Buy As You Earn Share Incentive Plan, as part of a regular monthly purchase of partnership shares. While the transaction is small in scale, it underscores ongoing executive participation in Cranswick’s employee share schemes, aligning management’s interests with shareholders and reflecting continued use of equity-based incentives within the company’s governance framework.

The most recent analyst rating on (GB:CWK) stock is a Hold with a £5500.00 price target. To see the full list of analyst forecasts on Cranswick stock, see the GB:CWK Stock Forecast page.

Cranswick Confirms Total Voting Rights and Share Capital Structure

Cranswick plc has confirmed that, as of 31 December 2025, it has 54,281,240 ordinary shares of 10 pence each in issue, with no shares held in treasury and each share carrying one voting right. This clarification of the company’s total voting rights provides shareholders and market participants with the denominator needed to assess and report any notifiable shareholdings or changes in holdings under the Financial Conduct Authority’s Disclosure and Transparency Rules, supporting regulatory compliance and transparency in the company’s share register.

The most recent analyst rating on (GB:CWK) stock is a Hold with a £5500.00 price target. To see the full list of analyst forecasts on Cranswick stock, see the GB:CWK Stock Forecast page.

Cranswick Director Adds Shares Under 2024 Buy As You Earn Plan

Cranswick plc disclosed that director Christopher Aldersley acquired three ordinary shares in the company on 22 December 2025 as Partnership Shares under its 2024 Buy As You Earn Share Incentive Plan, via a regular monthly purchase programme on the London Stock Exchange. The small, routine transaction underscores ongoing executive participation in Cranswick’s employee share schemes, aligning management interests with shareholders but does not indicate any change in strategy or have a material impact on the company’s operations or market position.

The most recent analyst rating on (GB:CWK) stock is a Hold with a £5500.00 price target. To see the full list of analyst forecasts on Cranswick stock, see the GB:CWK Stock Forecast page.

Cranswick Grants Discounted SAYE Share Options to Three Board Directors

Cranswick plc has granted new options over ordinary shares to three board directors under its Save As You Earn scheme, with Christopher Aldersley and James Brisby each receiving options over 374 shares and Chief Executive Adam Couch receiving options over 616 shares. The options, granted at an exercise price of 4,110 pence per share—representing a 20% discount to the reference market price—and exercisable over five years, underline the company’s ongoing use of all-employee share plans to align senior management and staff incentives with shareholder interests and future share price performance.

The most recent analyst rating on (GB:CWK) stock is a Hold with a £5500.00 price target. To see the full list of analyst forecasts on Cranswick stock, see the GB:CWK Stock Forecast page.